4.0
Mar 29, 2009
Former employee
Seattle, WA
Recommend
CEO approval
Business outlook
Pros
1. Clear strength in early stage discovery of protein therapeutics. A good place to be a scientist. 2. Very good benefits. Not sure if it is specific to Seattle and somewhat impacted by Boeing/Microsoft, but the Health Benefits are extremely generous. 3. Everyone is very respectful.
Cons
1. Clear weakness in commercial/business of biotech. 2. Lacking strong revenues to expand business. Recothrom sales to date have been lackluster- why not split the company between the future cash cow and the important new medicines of the future? 3. This company needs some energy from the top down. The IPO buzz started fading circa 2003.